kevin m. miller, md - Jules Stein Eye Institute

More documents

Recommendations

Info

$ucla laser refractive center informed consent$

Kevin M. Miller, MD page 18 revised: April 4, 2011 Phase III U.S. Food and Drug Administration Clinical Trial Staar Surgical Company Monrovia, California (unfunded) 2001-2004 “Clinical Evaluation of the OCULAID Endocapsular Tension Ring (CTR) for the Management of Zonular Weakness or Dialysis during and/or after Cataract Extraction” Phase III U.S. Food and Drug Administration Clinical Trial Ophtec USA Boca Raton, Florida (unfunded) 2002-present “Clinical Investigation of the ACRYSOF® Single-Piece Toric Intraocular Lens” Phase III U.S. Food and Drug Administration Clinical Trial Alcon Laboratories Fort Worth, Texas ($76,780) 2003-2004 “Clinical Evaluation of Two Artificial Iris Implants” UCLA Academic Senate Faculty Grant Program Los Angeles, California ($7,500) 2004-present “Clinical Study of Implantation of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens” Phase III U.S. Food and Drug Administration Clinical Trial HOYA Corporation Medical Division Tokyo, Japan ($82,000) 2008-present “Morcher Iris Diaphragm Study” Phase I/II Compassionate Use Food and Drug Administration Clinical Trial Carl & Roberta Deutsch Foundation Los Angeles, California ($25,000 in 2009-2010) Protocols Approved for Human Investigation 1988-1989 "Recognition-Equivalent Infant Visual Acuity - Phase I" Approved by the Joint Committee on Clinical Investigation, Johns Hopkins University and Johns Hopkins Hospital 1988-1989 "Recognition-Equivalent Infant Visual Acuity - Phase II" Approved by the Joint Committee on Clinical Investigation, Johns Hopkins University and Johns Hopkins Hospital
Kevin M. Miller, MD page 19 revised: April 4, 2011 1988-1989 "Recognition-Equivalent Infant Visual Acuity - Phase III" Approved by the Joint Committee on Clinical Investigation, Johns Hopkins University and Johns Hopkins Hospital 1992-1994 "Investigation of Possible Ocular Toxicity of Glimepiride" Hoerchst Roussel Pharmaceuticals Inc. HOE 490 Protocol 301 Amendment II Approved by the UCLA Human Subjects Protection Committee 1993-1994 "The Role of Preoperative Antibiotics in Cataract Surgery" with Steven O. Rimmer, MD and Leonard Apt, MD Approved by the UCLA Human Subjects Protection Committee 1998-present “Functional Visual Outcomes of Cataract Surgery” Approved by the UCLA General Campus Human Subject Protection Committee 1999-2000 “Clinical Evaluation of the Staar Surgical Implantable Contact Lens for Myopic and Hyperopic Patients” with Michael Olson, OD, PhD Phase III U.S. Food and Drug Administration Clinical Trial, approved by the UCLA Medical Human Subjects Protection Committee 2001-2004 “Clinical Evaluation of the OCULAID Endocapsular Tension Ring (CTR) for the Management of Zonular Weakness or Dialysis during and/or after Cataract Extraction” with Michael Olson, OD, PhD Phase III U.S. Food and Drug Administration Clinical Trial, approved by the UCLA Medical Human Subjects Protection Committee 2002-2004 “Clinical Investigation of the ACRYSOF® Single-Piece Toric Intraocular Lens” with Michael Olson, OD, PhD Phase III U.S. Food and Drug Administration Clinical Trial, approved by the UCLA Medical Human Subjects Protection Committee 2002-present “Ophtec Model 311 Iris Reconstruction Lens for the Treatment of Visual Disturbances Resulting from Partial and Complete Absence of the Human Iris” with Michael Olson, OD, PhD
Page 1 and 2: Personal KEVIN M. MILLER, MD CURRIC
Page 3 and 4: Kevin M. Miller, MD page 3 revised:
Page 11 and 12: Kevin M. Miller, MD page 11 revised
Page 17: Kevin M. Miller, MD page 17 revised
Page 69 and 70:
Kevin M. Miller, MD page 69 revised
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Kevin M. Miller, MD page 101 revise
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
show all

kevin m. miller, md - Jules Stein Eye Institute

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?